# Society for Family Planning

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/society-for-family-planning
Canonical HTML page: https://getyourbrief.com/entity/society-for-family-planning

## Timeline

- **2026-09-09**: 5th Circuit hears mifepristone arguments — Louisiana AG Liz Murrill and Rosalie Markezich argue for tighter prescribing rules before a three-judge panel in New Orleans.
- **2026-09-09**: 5th Circuit hears mifepristone arguments — Louisiana AG Liz Murrill and Rosalie Markezich argue for tighter prescribing rules before a three-judge panel in New Orleans.
- **2025**: Louisiana pill access estimated at 770–900 monthly — A Society for Family Planning survey estimates that 770–900 Louisiana women per month obtained abortion pills from out-of-state providers under shield laws.
- **2025**: Louisiana pill access estimated at 770–900 monthly — A Society for Family Planning survey estimates that 770–900 Louisiana women per month obtained abortion pills from out-of-state providers under shield laws.
- **2022-06-24**: Supreme Court allows states to decide abortion issue — The Dobbs decision clears the path for state abortion bans and sets up the current legal battles over cross-border medication abortion.
- **2022-06-24**: Supreme Court allows states to decide abortion issue — The Dobbs decision clears the path for state abortion bans and sets up the current legal battles over cross-border medication abortion.

## Recent coverage (3 stories, network-wide)

### 5th Circuit weighs mifepristone limits as 770–900 LA women get pills monthly
2026-09-09 21:58:41 · Sector: legal · Sentiment: Negative · Impact: 7/10 · Sources: 2

A Fifth Circuit panel is weighing whether federal courts or the FDA should govern mifepristone prescribing, with state shield laws and cross-border pill access at issue. The case is one of three appeals seeking to restrict medication abortion.
Full story: https://getlegalbrief.com/story/5th-circuit-mifepristone-prescribing-legal-challenge

### 3 in 5 US abortions now rely on mifepristone as court weighs limits
2026-09-09 21:58:31 · Sector: health · Sentiment: Negative · Impact: 7/10 · Sources: 2

Medication abortion accounts for at least 60% of U.S. abortions, and a lawsuit could restrict mifepristone prescribing in states where abortion is legal. Clinicians and telehealth providers face uncertainty over cross-border prescriptions and FDA rules.
Full story: https://gethealthbrief.com/story/mifepristone-access-healthcare-court-challenge

### 3 in 5 abortions use mifepristone as 5th Circuit weighs limits
2026-09-09 21:58:20 · Sector: bio · Sentiment: Negative · Impact: 7/10 · Sources: 2

For biopharma, the dispute over mifepristone prescribing rules is a test of FDA regulatory authority over an approved drug's risk evaluation and mitigation strategy. The case may influence how drug safety restrictions are litigated and how federal preemption applies to medication abortion.
Full story: https://getbiobrief.com/story/mifepristone-rems-fda-5th-circuit-biopharma

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.